Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Qualitative Stage
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Men with high-risk BCR PCa but no ADT+/-ARPI experience.
• Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.
Locations
Other Locations
Australia
Kinghorn Cancer Centre
RECRUITING
Sydney
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2026-11-30
Participants
Target number of participants: 24
Treatments
Experimental: A qualitative approach with semi-structured interviews.
Through purposive sampling, we plan to conduct interviews with men from two groups: those with high-risk BCR PCa but no ADT+/-ARPI experience, and men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment. To inform an understanding of how perception of breast-related symptoms might inform treatment preferences, it is important to understand perspectives regarding the hypothetical risk of side-effects as well as those based on actual experience.
Related Therapeutic Areas
Sponsors
Leads: St Vincent's Hospital, Sydney
Collaborators: University of Technology, Sydney